Stephanie Andriamiharisoa | Infectious Disease | Best Researcher Award

Published on by Global Mechanics Awards

Dr. Stephanie Andriamiharisoa | Infectious Disease | Best Researcher Award

Lecturer | University of Mahajanga | Madagascar

Dr. Stéphanie Norotiana Andriamiharisoa, épouse Raotoson, is a Malagasy physician and academic specializing in internal medicine. Born in Antananarivo, Madagascar, she has built a distinguished medical and academic career combining clinical excellence, research, and teaching. She currently serves as a Lecturer-Researcher at the University of Mahajanga and as Chief of Clinic in Internal Medicine at the University Hospital Center (CHU) Mahavoky Atsimo, Mahajanga. Passionate about advancing healthcare in resource-limited settings, she has contributed significantly to research in nephrology, infectious diseases, autoimmune conditions, and epidemiology. Dr. Andriamiharisoa has authored numerous peer-reviewed publications and presented her work at both national and international conferences. Recognized for her scholarly contributions, she has received multiple distinctions, including jury commendations for her doctoral thesis and specialist dissertation. Beyond her academic pursuits, she has also demonstrated leadership, serving as president of the Health Personnel Mutual of CHU Mahavoky. She is married and mother of three children.

Professional Profile

Orcid

Education

Dr. Andriamiharisoa began her medical studies in at the Faculty of Medicine, Antananarivo, Madagascar. She completed her undergraduate medical education an, earned her Doctor of Medicine (MD) degree with a thesis on peripartum cardiomyopathy, awarded with high honors and jury commendation. Pursuing specialization in internal medicine, she undertook postgraduate training at CHU Joseph Raseta Befelatanana, Antananarivo, from onward. She consolidated her expertise through diverse academic and clinical experiences, including a clinical internship in Hematology at the Centre Hospitalier d’Argenteuil, Franct, she successfully defended her specialist dissertation on chronic kidney disease at CHU Mahavoky, which earned her the Diplôme d’Études de Formation Spécialisée (DEFS) in Internal Medicine, also with high distinction. Her advanced training culminated in November, marking the completion of her specialized medical studies. Her academic journey reflects a rigorous commitment to excellence in both clinical practice and research.

Experience

Dr. Andriamiharisoa has accumulated extensive professional experience in internal medicine and medical research. She began as a medical intern at CHU Joseph Raseta Befelatanana, progressing to a hospital-based internship in France in she was appointed Assistant Physician in Internal Medicine at CHU Mahavoky Atsimo, Mahajanga, where she quickly advanced to Chief of Clinic. In parallel, she has been serving as a Lecturer-Researcher at the University of Mahajanga since, combining clinical duties with medical education and scientific inquiry. Her clinical expertise spans nephrology, infectious diseases, autoimmune disorders, and critical care, addressing pressing health challenges in Madagascar. She has also supervised research, mentored students, and actively contributed to professional societies. Her leadership was highlighted when she was elected President of the Health Personnel Mutual at CHU Mahavoky. Her career demonstrates a balance between patient care, academic scholarship, and healthcare leadership.

Research Focus

Dr. Andriamiharisoa’s research focuses on internal medicine with a strong emphasis on diseases prevalent in Madagascar and resource-limited settings. Her interests include nephrology, particularly the epidemiology and clinical features of chronic kidney disease, as well as metabolic disorders such as obesity and diabetes. She has conducted significant research on infectious diseases, including tuberculosis, nosocomial infections, and methicillin-resistant Staphylococcus aureus, providing valuable insight into public health challenges. Additionally, she has explored autoimmune conditions such as systemic lupus erythematosus and systemic scleroderma, shedding light on diagnostic and therapeutic difficulties in low-resource contexts. Dermatological case reports, cardiovascular diseases, and pediatric infections also form part of her diverse portfolio. Through her publications and presentations, she highlights the unique clinical patterns observed in Malagasy populations while contributing to global discussions on tropical medicine and internal medicine. Her ultimate research aim is to strengthen evidence-based practice and improve patient outcomes in Madagascar.

Awards and Honors

Dr. Andriamiharisoa has consistently been recognized for her academic and clinical excellence, her doctoral thesis on peripartum cardiomyopathy received the distinction of “Très honorable” with jury congratulations and a proposal for the thesis prize, reflecting both the quality and clinical relevance of her work. Similarly, her specialist dissertation on chronic kidney disease in Mahajanga earned the same distinction, with additional commendations for its scientific rigor and contribution to understanding epidemiological and clinical patterns in Madagascar. Beyond these academic accolades, her leadership was acknowledged when she was elected president of the CHU Mahavoky Health Personnel Mutual an honor reflecting both professional trust and commitment to community service. Her contributions in research and education have also been highlighted through multiple invitations to present at national and international conferences. These honors illustrate her dedication to advancing medical knowledge and healthcare practice in Madagascar.

Publication Top Notes

Simulation-Based Education to Improve Hand Hygiene Practices: A Pilot Study in Sub-Saharan Africa
Year: 5025

Conclusion

Dr. Andriamiharisoa’s impressive academic background, research experience, and clinical expertise make her a strong candidate for the Best Researcher Award. Her leadership roles and publication record further demonstrate her capabilities. With some additional interdisciplinary collaboration, international impact, and research funding, she could further solidify her position as a leading researcher in her field.

Prof. Dr. Ilker UCKAY | Infektiologie | Best Researcher Award

Published on by Global Mechanics Awards

Prof. Dr. Ilker UCKAY | Infektiologie | Best Researcher Award

Prof. Dr. med, at Balgrist, Switzerland.

Prof. Dr. med. Ilker Uçkay is a renowned physician-scientist specializing in infectious diseases and infection control. Born on May 10, 1970, in Uzwil, Switzerland, he has made significant contributions to the field of orthopedic infections and antibiotic stewardship. With expertise in multiple languages, including German, French, Turkish, English, and Italian, Prof. Uçkay has collaborated with international teams to advance research and clinical practice.

Professional Profile

Google Scholar

🎓 Education

– *Federal Diploma of Medicine*, University of Zurich, Switzerland (1995) 💊– *Doctor Thesis*, University of Zurich, Switzerland (1996) 🔬– *Swiss Federal Diploma in Internal Medicine* (2001) 💼– *Swiss Federal Diploma in Infectious Diseases* (2006) 🧬– *Advanced Course of Epidemiology*, London School of Hygiene and Tropical Medicine (2006) 📚– *Habilitation*, University of Geneva (2012) 🎓– *Titular Professorship*, University of Zurich (2019)

💼 Experience

– *Attending Lead Infectiology*, Balgrist University Hospital, Switzerland (2018-present) 💼– *Attending*, Geneva University Hospitals, Switzerland (2009-2018) 🏥– *Resident*, Geneva University Hospitals, Switzerland (2001-2009) 👨‍⚕️– *Head of Unit for Clinical and Applied Research*, Balgrist University Hospital, Switzerland (2018-2024)

🔬 Research Interests

– *Orthopedic Infections*: prevention, diagnosis, and treatment 🔬– *Antibiotic Stewardship*: optimizing antibiotic use in orthopedic infections 💊– *Infection Control*: reducing healthcare-associated infections

🏆 Awards

– *Best Paper in Epidemiology*, ICAAC Programme Committee Award (2010) 🏆– *Best Poster*, Annual Meeting of the Swiss Society for Orthopaedic Surgery (2013) 📚– *Best Research*, Annual Meeting of the Swiss Society for Orthopaedic Surgery (2013) 🔬– *Prix Marko Müller*, Annual Meeting of the Swiss Society for Orthopaedic Surgery (2015) 🏆– *Neviaser Award*, Journal of Shoulder and Elbow Surgery (2023) 🏆– *Fellow in the Royal Academy of Physicians*, London, England (2024)

📚Top Noted  Publications

– Short Duration of Antibiotic Prophylaxis in Gustilo Grade III Open Extremities Fractures 🔬
– Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae 🧬
– No need for search of asymptomatic urinary tract colonization before elective hip and knee arthroplasty 🏥
– Administration of antibiotic agents before intraoperative sampling in orthopedic infections 💊
– Short postsurgical antibiotic therapy for spinal infections 🔬
– A postoperative initially inadequate antibiotic treatment is not associated with an increased risk of therapy failures 📊

Conclusion

Prof. Ilker Uçkay’s impressive research record, leadership roles, and awards make him a strong candidate for the Best Researcher Award. His contributions to orthopedic infections and antibiotic stewardship have significant clinical implications. By further emphasizing translational research, global health, and mentorship, Prof. Uçkay could strengthen his application and demonstrate his potential for continued excellence in research.

Nitin Pal Kalia | Infectious diseases | Best Researcher Award

Published on by Global Mechanics Awards

Dr. Nitin Pal Kalia | Infectious diseases | Best Researcher Award

Assistant Professor at  NIPER HYDERABAD, India

Changmin Shi is a Postdoctoral Research Associate at Brown University, specializing in energy materials mechanics and thermal energy management. With extensive experience in materials science and engineering, he has contributed to groundbreaking research on high-energy-density lithium-sulfur batteries and innovative solutions for energy storage and thermal regulation. His work is aimed at advancing battery performance, enhancing materials for space thermoregulation, and developing recyclable battery technologies. Changmin’s research has garnered significant funding and continues to shape the future of energy-efficient systems.

 

Professional Profiles:

Google scholar

Education🎓

Brown University (2023–Present) – Postdoctoral Research Associate, School of Engineering University of Maryland (2019–2023) – Ph.D. in Materials Science and Engineering, Dissertation on Lithium-Sulfur Batteries Columbia University (2017–2019) – M.S. in Materials Science and Engineering, Research on Flexible Lithium-ion Batteries University of Science and Technology Beijing (2013–2017) – B.Eng. in Metallurgical Engineering, Research on PEM Fuel Cell Materials

Experience🔬

Postdoctoral Research Associate at Brown University, School of Engineering (2023–Present) Ph.D. Researcher at University of Maryland, focusing on lithium-sulfur batteries and energy materials (2019–2023) Graduate Research Assistant at Columbia University, specializing in flexible energy storage systems (2017–2019) Research Assistant at University of Science and Technology Beijing, focusing on PEM fuel cell materials (2013–2017)

Awards and Honors🏅

“Battery-Driven Systems Enabled Materials Thermoregulation” funding from LiquidMetal, $250,000 (2025–2027) “Blocking Li Metal Dendrites with Piezoelectric Solid Polymer Electrolytes” funding, $90,013 (2023–2024) Initiative for Sustainable Energy Funding for “Hierarchically-Structured Coatings for Thermal Energy Management,” $90,774 (Proposal submission) Research Grants and Proposals from NSF and other funding agencies

Research Focus🔬

Battery Technology – Development of safe, high-energy-density batteries with advanced materials Thermal Energy Management – Innovations in space thermoregulation and passive radiation cooling systems  Recyclable Energy Systems – Novel approaches to sustainable, recyclable battery technologies  Energy Materials Mechanics – Investigating mechanical properties of energy materials, including elasticity, plasticity, fracture toughness, and flexibility

✍️Publications Top Note :

“Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus”
This study, published in Journal of Antimicrobial Chemotherapy (2012), identifies capsaicin as an effective inhibitor of the NorA efflux pump, reducing the invasion of Staphylococcus aureus. The research was co-authored by NP Kalia and others.

“Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection”
Published in Proceedings of the National Academy of Sciences (2017), this paper investigates how targeting the synthetic lethality of terminal respiratory oxidases can clear Mycobacterium tuberculosis infections, offering potential therapeutic strategies.

“Sulfur-rich 2-mercaptobenzothiazole and 1, 2, 3-triazole conjugates as novel antitubercular agents”
This article in the European Journal of Medicinal Chemistry (2014) discusses the synthesis and antitubercular properties of sulfur-rich conjugates, with NP Kalia contributing to the study.

“Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors”
A 2008 publication in Bioorganic & Medicinal Chemistry, which presents piperine analogs as inhibitors of the NorA efflux pump in Staphylococcus aureus, a key player in antibiotic resistance.

“Protective efficacy of piperine against Mycobacterium tuberculosis”
In this 2014 Tuberculosis journal article, the protective effect of piperine against Mycobacterium tuberculosis is evaluated, with NP Kalia contributing to the study.

“Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus”
Published in Journal of Medical Microbiology (2011), this study explores the potential of piperine to inhibit the MdeA efflux pump, which is involved in antibiotic resistance in Staphylococcus aureus.

“Antimicrobial and Antimycobacterial Activities of Methyl Caffeate Isolated from Solanum torvum Swartz. Fruit”
In this 2012 Indian Journal of Microbiology article, methyl caffeate isolated from Solanum torvum fruit is evaluated for its antimicrobial and antimycobacterial properties.

“Dual inhibition of the terminal oxidases eradicates antibiotic‐tolerant Mycobacterium tuberculosis”
A study in EMBO Molecular Medicine (2021), where the dual inhibition of terminal oxidases is shown to eradicate antibiotic-tolerant Mycobacterium tuberculosis.

Conclusion

Changmin Shi is undoubtedly a strong contender for the Best Researcher Award. His innovative contributions to energy materials, mechanical devices for material characterization, and high-energy-density battery systems are transformative in both the academic and industrial research spaces. His proactive approach in securing funding, initiating research ideas, and collaborating with key industry players positions him as a future leader in materials science and engineering.